GREG MACOMBER

Email: gregmacomber@comcast.net Home: 215.794.5781 | Mobile: 949.433.2702 New Hope, Pennsylvania 18938

Director of Global Oncology/Pharmaceutical Sales Initiatives & Pre-Launch Marketing Specialist

Specialty Areas Include
Building & Leading High-Performance Sales Teams New Product Rollouts Analyzing Market Trends Competitive Product Positioning Relationship/Solution Selling Creating Strategic Partnerships & Alliances Bachelor Degreed, Director of Global Oncology/Pharmaceutical Sales Initiatives & Pre-Launch Marketing Specialist, with more than 20 years of revenue generation and pre-launch marketing experience in identifying strategic avenues that have strengthened new and existing business initiatives for Bristol-Myers Squibb Oncology and Ogilvy CommonHealth Worldwide. Experience encompasses serving as Regional Business Director of Sales for Bristol-Myers Squibb, charged with managing 72 employees across a 27 western state U.S. region that generated $320 million in annual gross revenue.

Career Highlights

Awarded Best Performer Award twice as Regional Business Director; generated $320 million in oncology portfolio gross revenue and exceeded launch year Erbitux sales goal by 15%. In advance of launch, triggered regional initiatives designed to significantly improve selling skills and productivity, while reinforcing successful behaviors through best practice sharing. Exceeded as Marketing Brand Director sales goal for 13-year old oncology brand, Paraplatin, by delivering $740 million in gross revenue. Charged with managing a 5-member marketing team to develop key strategies, namely building major congress plans around late-breaking clinical data to catalyze brand growth trends. As Director of Global Marketing, managed and enabled an 8-member cross-functional matrix team to build highly competitive brand Life Cycle Management (LCM) strategies by developing and receiving endorsement for a methodology to indentify future brand indications with high potential. Recipient of Best Performer Award - District Business Manager by delivering $75 million in oncology portfolio gross revenue. Subsequently accomplished the following 2 items: 1) Drove 32% sales growth for flagship brand, Taxol, thereby exceeding goal by 18%; and 2) Rebuilt a sales district through effectively hiring, training and developing 5 talented sales representatives.

Benefit Statement
Demonstrated 20+ year track record of accomplishments in improving regional sales productivity, implementing best practices, pre-launch marketing, identifying future brand indications with high sales potential and managing and enabling cross-functional matrix teams to build Life Cycle Management (LCM) strategies with the goal of optimizing brand revenue generation.

Key Areas of Expertise

Exceeding Sales Call Quotas Formal Presentation Skills Building Brand Awareness Forming & Leveraging Strategic Alliances Directing Special Sales & Promotional Projects Sales Leadership by Example Conflict Resolution Go-ToMarket Strategies

Professional Experience & Accomplishments

Ogilvy CommonHealth Worldwide (OCH), Parsippany, New Jersey & CREO Healthcare Communications, Bridgewater, New Jersey
2008 to November, 2011
(OCH is a large, global, full-service agency focused on developing healthcare brands for its clients; CREO is a small boutique agency focused on developing unbranded disease-state and medical education)

Senior Vice President, Agency Account Supervisor Scope of duties for both positions consisted of acquiring new clients
and developing messaging strategies for oncology brands while simultaneously managing internal account staff, including account executives, business managers, medical writers, creative designers and copy editors in the delivery of client services.

Greg Macomber

Page Two

Acquired over a 3-year period, 6 new major pharmaceutical clients that generated a combined $4.5 million in new business revenue. Developed the scientific messages for a phase III targeted therapy plus companion diagnostic test; messages are currently embedded in brand global communication platform. 1990 to 2008

Bristol-Myers Squibb Oncology (BMSO), Princeton, New Jersey & Aliso Viejo, California
(One of the premier oncology brand manufacturers and providers in the pharmaceutical industry)

Director, Global Marketing, Brand Life Cycle Management Lead (2005-2008) Primary duties focused on managing and enabling an 8-member cross-functional matrix team to build brand LCM strategies by developing and receiving endorsements for a methodology designed to identify future brand indications with high potential.

Indications identified currently represent the brand (Yervoy) clinical development strategy and are being evaluated in Phase III trials.

Regional Business Director, Oncology Sales (2002-2005) Responsibilities included triggering regional initiatives to
significantly improve selling skills and productivity, while simultaneously reinforcing successful behaviors through best-practice sharing.

Awarded Best Performer in 2003 and again in 2004 by delivering $320 million in oncology portfolio gross revenue in latter year and exceeding launch year Erbitux sales goal by 15%; led Western Region to Paraplatin (carboplatin) sales attainment of 109%, tops in the nation, by producing YTD sales growth of 28% in year 14 of brand life cycle.

Brand Director, Oncology Marketing (1999-2002) Charged with developing budget, objectives, strategies and tactics
related to mature, high-dollar volume oncology brand.

Promoted from Product Manager, to Senior Product Manager, to Director of Portfolio Breast Cancer Indications; developed strategy resulting in #1 brand market share for Taxol in the breast cancer market place in 1999. Exceeded sales goals for Paraplatin, a 13-year old oncology brand, as Brand Director by delivering $740 million in gross revenue in 2001. To accomplish this, managed marketing team of 5 to develop key strategies, namely building major congress plans around late-breaking clinical data to catalyze brand growth trend.

District Business Manager, Oncology Sales (1997-1998) Responsibilities and accomplishments included leading and
developing 9 sales representatives and hiring and training 5 of them, resulting in 3 being promoted to positions of greater responsibility.

Awarded Best Performer status in 1998, by delivering $75 million in oncology portfolio gross revenue. To accomplish this drove 32% year-over-year sales growth for flagship brand, Taxol, and exceeded established corporate sales goal by 18%.

Associate Manager of Sales Training, Oncology (1996) Charged with effectively planning and preparing classroom
training of newly hired oncology sales representatives.

Praised by senior management for ability to train new hires on product, competitive and disease state profiles and consequently promoted to District Business Manager within 1 year.

Senior Territory Business, Manager Pharmaceutical Sales (1989-1995) Responsible for routing, targeting and selling
activities in Brooklyn, New York City and Pittsburgh, Pennsylvania territories, exceeding overall product sales goals for 5 consecutive years.

Exceeded overall product sales goals for 5 years with BMSO while in territory through focus on sales presentation skills, ongoing customer relationships and customer trustworthiness in Brooklyn, New York and Pittsburgh, Pennsylvania. Ranked #1 in district sales attainment in 1989 with Fisons Pharmaceuticals, selling allergy and asthma brands in Manhattan, New York.

Education
Bachelor of Arts, Denison University, Granville, Ohio, 1988

Greg Macomber Endorsements

Page Three

Greg drives performance with a sense of urgency. This approach and his customer focus helped him lead his team to the #1 finish, and will continue to serve him well moving forward. Greg has a very diverse management team, including managers with very long tenure. His individualistic approach to each is very welcomed by his management team. Greg does well communicating successes, always accentuating the positive, and delivers the difficult message when necessary. He also exercises good judgment around personnel issues. Frank Pasqualone SVP Oncology Sales and Marketing Bristol-Myers Squibb Greg is excellent at driving performance. He has been able to drive performance of specific team members who had been under-achieving by clearly defining goals and expectations and creating a sense of accountability. Richard Kim Senior Director Global Marketing Bristol-Myers Squibb Greg brings a positive, can-do attitude to work every day. Specifically, for a team member who has been perceived by others as underperforming, Greg has been able to instill a sense of purpose that has re-energized this individual. He sees the cup half full and not half empty. Greg demonstrated strong ability to lead strategically by developing a framework for evaluating 14 different potential business opportunities and then led the work to evaluate and rank-prioritize the top 7. This work ultimately led to the selection of the top 3 opportunities, which ultimately received senior management endorsement and PRI funding for further development. This opportunity matrix approach to quickly evaluate a number of business opportunities has been emulated by other brand development teams. Chaunce Bogard VP Development Champion Bristol-Myers Squibb